← Back to guidelines
Psychiatry4 papers

Recurrent major depressive episodes, moderate

Last edited: 4/10/2026

Overview

Recurrent major depressive disorder is characterized by repeated episodes of depression. Management focuses on achieving remission of the current episode and preventing future episodes.

Diagnosis

  • Diagnosis of recurrent major depressive disorder requires a history of at least two distinct major depressive episodes 1.
  • Assessment should include evaluation of current symptoms, history of past episodes, and risk factors for recurrence 1.
  • Management

  • Treatment aims to achieve remission of the current episode and prevent relapse and recurrence 1.
  • Pharmacological treatment is a cornerstone of management for recurrent major depressive disorder 1.
  • Selection of antidepressant medication should consider efficacy, tolerability, and patient preference 1.
  • Maintenance treatment is crucial for preventing further episodes 1.
  • Duration of treatment should be individualized, with longer durations recommended for patients with recurrent episodes 1.
  • Key Recommendations

  • Pharmacological treatment is recommended for depressive episodes and recurrent depressive disorder 1. (Evidence: Moderate)
  • Treatment should include assessment of efficacy, monitoring, and appropriate duration 1. (Evidence: Moderate)
  • Maintenance treatment is important for preventing future depressive episodes in patients with recurrent disorder 1. (Evidence: Moderate)
  • References

    1 Samochowiec J, Dudek D, Kucharska Mazur J, Murawiec S, Rymaszewska J, Cubała WJ et al.. Pharmacological treatment of a depressive episode and recurrent depressive disorder - guidelines of the Polish Psychiatric Association and the National Consultant for Adult Psychiatry. Psychiatria polska 2021. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG